Indian Journal of Obstetrics and Gynecology Research
Official Publication of Innovative Education and Scientific Research Foundation
Official Publication of Innovative Education and Scientific Research Foundation
Print ISSN: 2394-2746
Online ISSN: 2394-2754
CODEN : IJOGCS
Indian Journal of Obstetrics and Gynecology Research (IJOGR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...Original Article
Author Details :
Volume : 5, Issue : 4, Year : 2018
Article Page : 559-562
https://doi.org/10.18231/2394-2754.2018.0125
Abstract
Objectives: To find out the effect of tranexamic acid on blood loss after vaginal delivery.
Materials and Methods: In this observational study, 100 women with a singleton pregnancy were allocated to receive one gram intravenous tranexamic acid or no drug in addition to 10 units of oxytocin after delivery of the fetus. Blood loss calculated by a graduated blood bag. Pre and post-delivery hemoglobin and hematocrit are determined.
Results: The mean blood loss (245ml vs 327 ml, p=<0> Conclusions: Tranexamic acid helps to reduce the amount of blood loss in vaginal delivery.
Keywords: Postpartum hemorrhage, Tranexamic acid, Vaginal delivery.
How to cite : Jayaraman Nambiar M, Somu K , The effect of tranexamic acid on blood loss after vaginal delivery. Indian J Obstet Gynecol Res 2018;5(4):559-562
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
